Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290612 · ClinicalTrials.gov registry record · NA
Vitamin C to Reduce Morning Cardiovascular Risk
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03290612 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 10 participants.
The verdict
NCT03290612, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will test the efficacy of Vitamin C to counteract morning cardiovascular (CV) risk markers in a randomized, double blind, placebo controlled crossover pilot study. The participants will also perform morning typical behaviors such as arousal from sleep, change in posture (getting out of bed) and mild intensity physical activity; identical to the stressors encountered in everyday life. Primary dependent variables are markers of cardiovascular risk including vascular endothelial function and oxidative stress.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-02-13 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03290612
The ClinicalTrials.gov registry entry for NCT03290612 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03290612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03290612 about?
NCT03290612 is a clinical study titled "Vitamin C to Reduce Morning Cardiovascular Risk". This study will test the efficacy of Vitamin C to counteract morning cardiovascular (CV) risk markers in a randomized, double blind, placebo controlled crossover pilot study. The participants will also perform morning typical behaviors such as arousal from sleep, change in posture (getting out of be...
What is the current status of trial NCT03290612?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-02-13. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT03290612?
The interventions under investigation include: Placebo (OTHER), Vitamin C (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03290612?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.